Atlas Trials

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

Clinical trial NCT01358084 · COMPLETED

Trial details

NCT number
NCT01358084
Sponsor
AGC Biologics S.p.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Malignant Pleural Mesothelioma
Start date
2011-03-01
Primary completion
2018-12-05
Enrollment
137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.